Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
In Vitro Experiment Equipment Supplied In Europe
5 equipment items found
Manufactured by:Tristel Solutions Ltd. based inSnailwell, UNITED KINGDOM
Daisygrip is the first hygienically reusable venous tourniquet and has a unique intuitive locking system. The simpler application and disinfection method ensure lasting safety and permanently reduce costs. With daisygrip, every routine blood sample is taken time-efficiently and under hygienic conditions, without changing current treatment procedures. A recently published study reaffirms the ...
Manufactured by:Quanta System S.p.A. based inSamarate, ITALY
Fiber Dust laser system is a Thulium Fiber Laser (TFL) surgical device intended for both Lithotripsy and precise soft tissue surgery. This device has a 1.9µm wavelength laser emission and is capable of super-pulsed mode to allow stone fragmentation and ablation. During the latest years, TFL technology emerged as a new alternative to Holmium laser, in particular for the treatment ...
Manufactured by:BOC Sciences based inShirley, NEW YORK (USA)
Celastrol (tripterine) is a chemical compound isolated from the root extracts of Tripterygium wilfordii (Thunder god vine) and Celastrus regelii. Celastrol is a pentacyclic triterpenoid and belongs to the family of quinone methides. In in vitro and in vivo animal experiments, celastrol exhibits antioxidant, anti-inflammatory, anticancer, and insecticidal ...
by:Pure Biologics SA based inWroclaw, POLAND
Colorectal cancer (CRC) is the second-most common cancer diagnosed in women and third-most in men. Based upon five-year survival rates, chances of becoming cured remain to be approximately 65%. Therapies targeting immunological checkpoints, or more specifically their inhibition, promise effective treatment options for patients with metastatic forms of this disease. In the PB001 project, Pure ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
SL-801 has demonstrated broad and SL-801 has demonstrated broad and potent preclinical activity in a wide array of solid and hematologic tumors, as well as neurologic disorders, in both in vitro and in vivo xenograft experiments. ...